This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (41)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

EDWARD OKUN, MD; PAUL A. CIBIS, MD

Arch Ophthalmol. 1966;75(3):337-352.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Diabetic retinopathy is becoming one of the most important causes of new blindness among the adult population of the United States. In 1930, it accounted for less than 1% of the cases of newly reported blindness. However, in 1960, more than 15% of reported cases of blindness were due to diabetic retinopathy, and there is every indication to believe that this percentage will become even higher in the years to come.¹ Not only are diabetics becoming more prevalent in the population, but with improved care many are now living long enough to manifest the retinopathy. In short, the therapy of clinical diabetes has been more successful than that of the vascular complications, and when the blood vessels of the eye deteriorate more rapidly than those which are necessary to maintain life, blindness ensues.

Diabetic retinopathy can be divided into a nonproliferative and proliferative stage. Microaneurisms, hemorrhages, and exudates characterize . . . [Full Text PDF of this Article]

Author Affiliations
St. Louis

From the Department of Ophthalmology and the Oscar Johnson Institute, Washington University, School of Medicine, St. Louis.; Deceased.

Footnotes
Submitted for publication April 19, 1965.

Reprint request to Department of Ophthalmology, Washington University School of Medicine, St. Louis 63110.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?